24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ALS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:53
How Musk’s X account floods feeds with pro-Trump messages and election misinformation
12:39
Harris vs. Trump: Competing visions for America's economic future
11:14
Is ChatGPT about to upend Google’s long-reigning search dominance?
10:46
Intel aims to net billions in Altera stake sale, targeting $17 billion valuation
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz eyeing Dazz acquisition in deal worth hundreds of millions
2
Four years and billions later, Intel’s Habana Labs is still searching for success amid layoffs
3
Intel's workforce questions its future amid layoffs and shrinking benefits
4
From Intel to Meta: How high-tech giants are rethinking employee perks
5
Sequoia-backed Decart raises $21M in Seed funding to pioneer scalable, cost-efficient GenAI
More news
ALS
5 stories about ALS
NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI
28.07.22
|
CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
Mind over Matter: The man who turned himself into a cyborg to overcome ALS
13.09.20
|
Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
05.08.19
|
Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
05.02.18
|
Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases
Please ensure Javascript is enabled for purposes of
website accessibility